Zacks Research Has Positive Outlook of MD FY2026 Earnings

Pediatrix Medical Group, Inc. (NYSE:MD) – Equities research analysts at Zacks Research lifted their FY2026 earnings per share estimates for Pediatrix Medical Group in a research report issued on Monday, March 10th. Zacks Research analyst Z. Masood now expects that the company will post earnings per share of $1.44 for the year, up from their prior estimate of $1.43. The consensus estimate for Pediatrix Medical Group’s current full-year earnings is $1.38 per share.

MD has been the subject of a number of other reports. Macquarie assumed coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 price target for the company. UBS Group increased their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a report on Friday, February 21st. Mizuho increased their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Tuesday, November 19th. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Finally, Truist Financial increased their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a report on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, Pediatrix Medical Group currently has an average rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Stock Performance

Shares of MD opened at $13.75 on Thursday. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $1.18 billion, a price-to-earnings ratio of -11.46, a PEG ratio of 1.74 and a beta of 1.48. The stock has a 50 day moving average of $14.13 and a 200 day moving average of $13.38. Pediatrix Medical Group has a 12 month low of $6.62 and a 12 month high of $17.67.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of large investors have recently made changes to their positions in MD. Principal Financial Group Inc. boosted its holdings in shares of Pediatrix Medical Group by 14.1% in the third quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock worth $5,953,000 after acquiring an additional 63,581 shares during the period. Atria Investments Inc boosted its holdings in shares of Pediatrix Medical Group by 9.0% in the third quarter. Atria Investments Inc now owns 27,124 shares of the company’s stock worth $314,000 after acquiring an additional 2,238 shares during the period. Royce & Associates LP boosted its holdings in shares of Pediatrix Medical Group by 19.0% in the third quarter. Royce & Associates LP now owns 197,372 shares of the company’s stock worth $2,288,000 after acquiring an additional 31,482 shares during the period. Empowered Funds LLC boosted its holdings in shares of Pediatrix Medical Group by 5.3% in the third quarter. Empowered Funds LLC now owns 266,838 shares of the company’s stock worth $3,093,000 after acquiring an additional 13,534 shares during the period. Finally, Quest Partners LLC boosted its holdings in shares of Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after acquiring an additional 622 shares during the period. 97.71% of the stock is owned by institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.